VALPROIC ACID - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for valproic acid and what is the scope of freedom to operate?
Valproic acid
is the generic ingredient in three branded drugs marketed by Bionpharma, Abbvie, Catalent, Hibrow Hlthcare, Par Pharm, Scherer Rp, Sun Pharm Inds Ltd, Upsher Smith Labs, Ani Pharms, Chartwell Rx, Hikma, Lannett Co Inc, Nostrum Labs Inc, Pharm Assoc, Pharmobedient Cnsltg, and Quagen, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.There are seventeen drug master file entries for valproic acid. Seventeen suppliers are listed for this compound.
Summary for VALPROIC ACID
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 16 |
NDAs: | 18 |
Drug Master File Entries: | 17 |
Finished Product Suppliers / Packagers: | 17 |
Raw Ingredient (Bulk) Api Vendors: | 144 |
Clinical Trials: | 189 |
Patent Applications: | 7,080 |
Drug Prices: | Drug price trends for VALPROIC ACID |
What excipients (inactive ingredients) are in VALPROIC ACID? | VALPROIC ACID excipients list |
DailyMed Link: | VALPROIC ACID at DailyMed |
Recent Clinical Trials for VALPROIC ACID
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Sohag University | Phase 2/Phase 3 |
Dr Cipto Mangunkusumo General Hospital | Phase 4 |
Wayne State University | Phase 4 |
Pharmacology for VALPROIC ACID
Drug Class | Anti-epileptic Agent Mood Stabilizer |
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Medical Subject Heading (MeSH) Categories for VALPROIC ACID
Anatomical Therapeutic Chemical (ATC) Classes for VALPROIC ACID
US Patents and Regulatory Information for VALPROIC ACID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Upsher Smith Labs | VALPROIC ACID | valproic acid | CAPSULE;ORAL | 070631-001 | Jun 11, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Nostrum Labs Inc | VALPROIC ACID | valproic acid | SYRUP;ORAL | 077105-001 | Jul 29, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pharm Assoc | VALPROIC ACID | valproic acid | SYRUP;ORAL | 075379-001 | Dec 15, 2000 | AA | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Abbvie | DEPAKENE | valproic acid | CAPSULE;ORAL | 018081-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lannett Co Inc | VALPROIC ACID | valproic acid | SYRUP;ORAL | 077960-001 | Oct 13, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Ani Pharms | VALPROIC ACID | valproic acid | SYRUP;ORAL | 073178-001 | Aug 25, 1992 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.